Francis I. Macedo

Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer

Francis I. Macedo, Emily L. Ryon, Shishir K. Maithel et al. · Annals of Surgery · 2019 · 161 citations · Full text

Medicine, Oncology, Surgery +13

Disparities in access to cancer surgery after Medicaid expansion

Jose Wilson Mesquita-Neto, Peter Cmorej, Hassan Mouzaihem et al. · The American Journal of Surgery · 2019 · 43 citations

Public Affairs, Health Policy, Surgery +14

Patterns of National Institutes of Health Grant Funding to Surgical Research and Scholarly Productivity in the United States

Jose Wilson Mesquita-Neto, William O. Dailey, Francis I. Macedo et al. · Annals of Surgery · 2020 · 24 citations

Public Affairs, Surgery, Health Services Research +16

Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy

Brianna L. Cohen, Amber L. Collier, Kristin N. Kelly et al. · Annals of Surgical Oncology · 2020 · 22 citations

Medicine, Oncology, Surgery +16

Does Neoadjuvant Chemotherapy Change the Role of Regional Lymphadenectomy in Pancreatic Cancer Survival?

Francis I. Macedo, Omar Picado, Peter J. Hosein et al. · Pancreas · 2019 · 13 citations

Medicine, Oncology, Surgery +17